Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia.
Karni S Moshal1, Naira Metreveli, Iuliana Frank
1Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Current Vascular Pharmacology
|April 9, 2008
Summary
Hyperhomocysteinemia (HHcy) impairs heart function by activating NMDA receptors and causing mitochondrial dysfunction. This review explores how homocysteine (Hcy) exacerbates cardiac issues via mitochondrial pathways.
Area of Science:
- Cardiology
- Mitochondrial Biology
- Neurocardiology
Background:
- Chronic heart failure involves oxidative stress and matrix metalloproteinase activation, leading to endothelial-myocyte uncoupling and impaired cardiac function.
- Elevated homocysteine (Hcy) levels, or hyperhomocysteinemia (HHcy), are linked to reduced cardiac performance, ventricular hypertrophy, cardiac stiffness, and diastolic heart failure.
- While N-methyl-D-aspartate receptors (NMDA-R) are implicated in Hcy-induced neurological defects and are present in the heart, their role in cardiac function during HHcy is not well understood.
Purpose of the Study:
- To elucidate the mitochondrial mechanisms by which Hcy contributes to the decline in cardiac mechano-electrical function and arrhythmogenesis through NMDA-R activation.
- To discuss the role of mitochondrial membrane potential (MMP) activation, protease stress, and mitochondrial permeability transition in cardiac conduction during HHcy.
- To investigate the potentiation between NMDA-R activation and mitochondrial defects in causing cardiac dysfunction during HHcy.
Main Methods:
- Review of existing literature on hyperhomocysteinemia, oxidative stress, NMDA receptor activation, and mitochondrial function in the context of heart failure.
- Analysis of the molecular pathways linking Hcy, NMDA-R, intracellular calcium handling, and mitochondrial dysfunction.
- Discussion of the role of cyclophilin D and the mitochondrial permeability transition pore in HHcy-induced cardiac pathology.
Main Results:
- Hcy increases intracellular calcium levels, activates calpain, and leads to mitochondrial abnormalities.
- Mitochondrial permeabilization and uncoupling in HHcy are driven by redox stress and calcium mishandling.
- Hcy amplifies mitochondrial membrane potential (mtMMP) activation via increased mitochondrial calcium overload and oxidative stress, leading to opening of the mitochondrial permeability transition pore.
Conclusions:
- Hcy-induced NMDA-R activation contributes to cardiac dysfunction and arrhythmogenesis through mitochondrial pathways.
- Mitochondrial dysfunction, including mtMMP activation and pore opening, plays a critical role in the mechano-electrical dysfunction observed in HHcy.
- Targeting NMDA-R and mitochondrial pathways may offer therapeutic strategies for managing HHcy-related cardiac complications.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

